Today we’re happy and proud here at DiabetesMine. By all accounts, the DiabetesMine Design Challenge we’ve hosted here for the past three years has been a roaring success. We inspired creative thinkers from all over the country and all over the world to design and showcase more than 300 innovative concepts. We helped place some of these talented young thinkers in key positions in the industry. And we managed – on a patient blog and…Read more »
Many of you have probably heard by now that J&J Animas was hit with a warning letter from FDA recently, and the accusations that they compromised patient safety by continuing to sell insulin pumps with known defects. This sounds pretty scary and negligent indeed. Why would a leading pump company do something so seemingly stupid? We called Animas spokesperson Caroline Pavis to get their side of the story.
Of course it’s the job of the…
The Artificial Pancreas has the potential to become a huge leap forward in diabetes care. As anxious as all of us are to push the boundaries in diabetes technology, we can’t forget the importance of clinical trials; nothing will move forward without real patients ready and willing to strap on the gear and let researchers observe them for hours on end, most of the time in a clinical setting.
That might not seem like the…Read more »
Roughly ten days ago, I was at the annual sprawling nexus of new consumer technology that takes place in Las Vegas every year, otherwise known as CES. For the second year in a row, a breakout event called the Digital Health Summit was a packed house, close to standing room only, as people swarmed in to find out what’s happening in the world of new health and medical devices, apps, and all manner of mobile…Read more »
More islet cell research to share with you today:
We’ve been covering quite a few companies working hard at finding ways to protect islets from immune system attack. First we profiled Cerco Medical, which is also the subject of a documentary film, and a couple of weeks ago we checked in with ViaCyte, of San Diego. Both of those companies are working with stem cells, but today’s company, Canada’s Sernova, is kicking it old school…